Kodiak Sciences, Inc. (KOD)
43.11
+0.75
(+1.77%)
USD |
NASDAQ |
Apr 10, 16:00
43.04
-0.06
(-0.15%)
Pre-Market: 20:00
Kodiak Sciences EPS Diluted (Quarterly) : -1.042 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tango Therapeutics, Inc. | -0.2945 |
| Eli Lilly & Co. | 7.024 |
| Catalyst Pharmaceuticals, Inc. | 0.4136 |
| Madrigal Pharmaceuticals, Inc. | -2.566 |
| ADMA Biologics, Inc. | 0.2025 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -56.74M |
| Total Expenses (Quarterly) | 56.74M |
| Enterprise Value | 2.616B |
| Earnings Yield | -10.03% |
| Normalized Earnings Yield | -9.970 |